Likarda
Likarda is a biotech company developing cell therapies for pets and people. Our cell delivery platform enables better encapsulation of cells for therapies, and can be made in durable or degradable formats. We are able to create microencapsulants using slow-gelling, advanced, biocompatible hydrogels including PEG, Hyaluronic Acid, and various other materials. This is achieved in a safe, cyto-compatible, biocompatible manner that can be produced at scale. Likarda is developing this platform for use in diabetes, osteoarthritis, joint pain, and inflammation. Likarda’s platform will enable the next generation of cell therapies to succeed for both pets and people.
